Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib

Author：                    

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.2, 2013-01, pp. : 741-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib – a Swedish model application

By Ghatnekar Ola   Hjalte Frida   Taylor Matthew  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 851-858

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib

By                                

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2835-2841

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients

By Paul T.  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 2, 2010-06 ,pp. : 56-61

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells

By Solmaz Soner   Adan Gokbulut Aysun   Cincin Birsu   Ozdogu Hakan   Boga Can   Cakmakoglu Bedia   Kozanoglu Ilknur   Baran Yusuf  

Nutrition and Cancer, Vol. 66, Iss. 4, 2014-05 ,pp. : 599-612

Routledge Ltd

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite